Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
Go back to Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress| (NASDAQ: CABA) | Delayed: 3.04 +0.03 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.01 | 52 Week High | $ | |||
| Open | $2.93 | 52 Week Low | $ | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $ | |||
| Volume | 653,021 | |||||
| (NASDAQ: CABA) | Delayed: 3.04 +0.03 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.01 | 52 Week High | $ | |||
| Open | $2.93 | 52 Week Low | $ | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $ | |||
| Volume | 653,021 | |||||

